FDA引证兰伯西违反了“良好生产规范”。

The FDA cited violations to “good manufacturing practice”.

youdao

辉瑞和兰伯西已锁定在争端关于立普妥的专利自2003年以来。

Pfizer and Ranbaxy have been locked in dispute regarding Lipitor patents since 2003.

youdao

专利侵权诉讼之间的辉瑞和兰伯西超过立普妥将继续在芬兰，西班牙，葡萄牙，丹麦和罗马尼亚。

Patent infringement litigation between Pfizer and Ranbaxy over Lipitor will continue in Finland, Spain, Portugal, Denmark and Romania.

youdao